[1]
K. Lazarević et al., “Monitoring of drug interactions in elderly patients with benign prostatic hyperplasia and cardiovascular diseases”, arhfarm, vol. 72, no. Suppl. 4, pp. S278-S279, Oct. 2022, Accessed: Nov. 19, 2026. Available: https://test.aseestant.ceon.rs/index.php/arhfarm/article/view/38409